MELANIE ORBEN: Open Payments
NPI 1669982377 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,383 in 129 payments from 15 companies in 2025. Trend: 2023 $3,742 · 2024 $5,767 · 2025 $6,383
Speaker / faculty: $4,080Food & beverage: $2,303
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 39 | $4,798 |
| Otsuka America Pharmaceutical, Inc. | 16 | $337 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $283 |
| Lundbeck LLC | 16 | $221 |
| Axsome Therapeutics, Inc. | 11 | $218 |
| ABBVIE INC. | 7 | $142 |
| Corium, LLC | 4 | $71 |
| Alkermes, Inc. | 3 | $70 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Almatica Pharma LLC | 3 | $52 |
Products named: CAPLYTA, REXULTI, TRINTELLIX, Auvelity, VRAYLAR, Azstarys, FANAPT, LOREEV XR.
Industry payments across FL — which companies pay providers there.
